- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 3PJ: N-[trans-4-(3-amino-3-oxopropyl)-4-phenylcyclohexyl]-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 29 residues within 4Å:- Chain A: G.22, A.23, S.24, K.25, G.26, I.27, A.46, R.47, S.48, G.72, T.73, M.74, N.100, H.101, I.102, Y.128, V.149, S.150, S.151, Y.164, K.168, L.196, G.197, L.198, I.199, T.201, T.203, A.204
- Ligands: 3PJ.1
31 PLIP interactions:31 interactions with chain A- Hydrophobic interactions: A:L.196
- Hydrogen bonds: A:S.24, A:S.24, A:K.25, A:K.25, A:I.27, A:R.47, A:S.48, A:T.73, A:T.73, A:M.74, A:E.75, A:N.100, A:N.100, A:I.102, A:Y.128, A:K.168, A:I.199, A:I.199, A:T.201, A:T.201, A:T.203, A:T.203
- Water bridges: A:G.22, A:K.25, A:G.28, A:R.47, A:S.48, A:T.203
- Salt bridges: A:K.25, A:R.47
NAP.4: 30 residues within 4Å:- Chain B: G.22, A.23, S.24, K.25, G.26, I.27, A.46, R.47, S.48, G.72, T.73, M.74, N.100, H.101, I.102, N.104, Y.128, V.149, S.150, S.151, Y.164, K.168, L.196, G.197, L.198, I.199, T.201, T.203, A.204
- Ligands: 3PJ.3
31 PLIP interactions:31 interactions with chain B- Hydrophobic interactions: B:L.196
- Hydrogen bonds: B:G.22, B:S.24, B:S.24, B:K.25, B:I.27, B:R.47, B:S.48, B:T.73, B:T.73, B:M.74, B:N.100, B:N.100, B:Y.128, B:K.168, B:I.199, B:I.199, B:T.201, B:T.203, B:T.203
- Water bridges: B:G.26, B:G.26, B:G.28, B:R.47, B:R.47, B:S.48, B:S.48, B:T.103, B:N.104
- Salt bridges: B:K.25, B:R.47
NAP.6: 29 residues within 4Å:- Chain C: G.22, A.23, S.24, K.25, G.26, I.27, A.46, R.47, S.48, G.72, T.73, M.74, N.100, H.101, I.102, Y.128, V.149, S.150, S.151, Y.164, K.168, L.196, G.197, L.198, I.199, T.201, T.203, A.204
- Ligands: 3PJ.5
30 PLIP interactions:30 interactions with chain C- Hydrophobic interactions: C:L.196
- Hydrogen bonds: C:S.24, C:S.24, C:K.25, C:K.25, C:I.27, C:R.47, C:S.48, C:T.73, C:M.74, C:N.100, C:N.100, C:I.102, C:Y.164, C:K.168, C:I.199, C:I.199, C:T.201, C:T.203, C:T.203
- Water bridges: C:G.22, C:K.25, C:G.28, C:R.47, C:S.48, C:T.103, C:T.103, C:T.203
- Salt bridges: C:K.25, C:R.47
NAP.8: 30 residues within 4Å:- Chain D: G.22, A.23, S.24, K.25, G.26, I.27, A.46, R.47, S.48, G.72, T.73, M.74, N.100, H.101, I.102, N.104, Y.128, V.149, S.150, S.151, Y.164, K.168, L.196, G.197, L.198, I.199, T.201, T.203, A.204
- Ligands: 3PJ.7
30 PLIP interactions:30 interactions with chain D- Hydrophobic interactions: D:L.196
- Hydrogen bonds: D:G.22, D:S.24, D:S.24, D:K.25, D:I.27, D:R.47, D:S.48, D:T.73, D:M.74, D:N.100, D:N.100, D:Y.164, D:K.168, D:I.199, D:I.199, D:T.201, D:T.201, D:T.203, D:T.203
- Water bridges: D:G.26, D:G.26, D:G.28, D:R.47, D:R.47, D:S.48, D:S.48, D:N.104
- Salt bridges: D:K.25, D:R.47
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sun, D. et al., Synthesis and Optimization of Novel 4,4-Disubstituted Cyclohexylbenzamide Derivatives as Potent 11beta-HSD1 Inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-10-05
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 3PJ: N-[trans-4-(3-amino-3-oxopropyl)-4-phenylcyclohexyl]-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sun, D. et al., Synthesis and Optimization of Novel 4,4-Disubstituted Cyclohexylbenzamide Derivatives as Potent 11beta-HSD1 Inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-10-05
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B